Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION (Tables)

v3.21.2
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of common stock options
                       
    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (Years)  
                   
Outstanding, December 31, 2020     5,500,135     $ 3.99       6.79  
Granted(a)     445,664       6.29          
Exercised     (16,439 )     4.75          
Forfeited     (155,932 )     4.22          
Outstanding, September 30, 2021(b)     5,773,428     $ 4.16       6.19  
Exercisable, September 30, 2021(c)     4,068,628     $ 3.76       5.32  

 

(a) The weighted average grant-date fair value of options granted during the nine months ending September 30, 2021 was $4.21 per share.
(b) The aggregate intrinsic value of all options outstanding as of September 30, 2021 was $14.6 million.
(c) The aggregate intrinsic value of all vested/exercisable options as of September 30, 2021 was $11.9 million.

 

Restricted Stock Awards

 

The following table sets forth the activity for all restricted stock awards:

 

    Number of Shares     Weighted Average Grant Date Fair Value     Weighted Average Remaining Contractual Life (Years)  
                   
Outstanding, December 31, 2020     337,187     $ 3.83       8.59  
Granted     25,566       6.29          
Forfeited     (17,282 )     2.08          
Outstanding, September 30, 2021     345,471     $ 4.10       8.37  
Schedule of common stock reserved for future issuance under employee stock plans
       
Plans   Number of Shares  
Total awards available to be issued     6,007,718  
Total options outstanding     5,773,428  
Total common stock reserved for future issuance under employee stock plans     11,781,146  
Schedule of summarizes share-based compensation expense
                               
    Three Months Ended
September 30,
   

Nine Months Ended

September 30,

 
    2021     2020     2021     2020  
Research and development   $ 214     $ 199     $ 682     $ 598  
Sales and marketing     140       103       476       309  
General and administrative     293       180       950       538  
Cost of sales     14       13       42       37  
Total share-based compensation   $ 661     $ 495     $ 2,150     $ 1,482